Venture capital firm based in London, UK
Bioliberty raises £7.6m to reduce post-acute readmissions with computer vision and AI. Read more
Bristol-based EnsiliTech secures £4.5 million in Seed funding to enhance biopharmaceutical access with innovative room-temperature technology. Read more
Just raised £7.8 million, Naturbeads is on a mission to revolutionize industries with biodegradable cellulose microbeads, turning the tide against microplastic pollution. Read more
Neupulse, a trailblazing spinout from the University of Nottingham, secures £500,000 to revolutionize Tourette’s syndrome treatment with an innovative wristband, pushing total funding to nearly £4.5 million and promising a game-changing non-drug therapy. Read more
Edinburgh's Chromacity is revolutionizing healthcare and agriculture with over £1 million in funding to launch groundbreaking laser technologies that promise to tackle pressing industry challenges. Read more
Edinburgh-based Carcinotech secures £4.2m funding to advance revolutionary 3D printed micro-tumour technology, revolutionizing drug screening and improving cancer treatment. Read more
| Healthtech | 55.6% |
| Biotech | 22.2% |
| Greentech | 11.1% |
| Mobility | 11.1% |